Αρχική World News Patients less likely to rate cancer care as ‘very good’ during pandemic

Patients less likely to rate cancer care as ‘very good’ during pandemic

Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK.

Whilst NHS staff have worked tirelessly throughout the crisis and many cancer patients have reported positive experiences of COVID-19 safety protocols, the impact of COVID-19 on cancer services and cancer patients has been devastating.

The charity hopes these figures will encourage governments to secure more long-term funding for cancer care in the UK.

Michelle Mitchell, Cancer Research UK’s chief executive, said: “COVID-19 hit the health system hard and cancer services suffered as a result, but even before the pandemic struck cancer targets were not being met. And now, for the first time in decades, we’re faced with the fact that cancer survival could go backwards.”

What did the survey find?

900 cancer patients were surveyed between December 2020 and March 2021. Of those asked, 29% experienced delays, cancellations or changes to their treatment.

More than 8 in 10 (84%) had recalled their care as being ‘very good’ pre-pandemic. However, almost 3 in 10 (31%) have subsequently downgraded their rating since the start of the pandemic.

Moreover, around 1 in 10 (12%) felt their previously ‘very good’ care had slipped to ‘average’ or below.

Emotional toll on cancer patients

For many patients, the uncertainty and fast-changing nature of the pandemic has led to an increased emotional toll on top of an already stressful diagnosis.

Around two-thirds of cancer patients reported feeling more ‘frustrated’ and ‘anxious’ since the pandemic began.

For Lorraine, who was diagnosed with multiple myeloma in 2014, the pandemic has made her anxiety worse.

Lorraine

Lorraine

Whilst her treatment has thankfully continued during this period, she is worried about what the end of restrictions will mean for her overall health.

She said: “I count myself so lucky that my chemo treatments have continued.

“But I am very anxious about the removal of face masks and social distancing. As someone that is vulnerable it feels like the Government is putting the needs of businesses and commerce ahead of the safety of people, and this feels like a step backwards.”

Some patients have faced additional trauma throughout the pandemic, with decisions around cancer treatments and surgery being made at the 11th hour.

One patient with breast cancer said: “On the day [of my mastectomy] the surgeon told me if [there were] no beds [I’d have to have] reconstruction at a later date… I was devastated.

Half an hour before surgery a bed became available, and my full surgery went ahead.”

The survey did also have some reassuring findings, with most cancer patients reporting positive experiences of COVID-19 safety measures. 89% of patients rated as ‘positive’ their experience of COVID-safe spaces, wearing masks (80%) and home and community-based treatment (75%).

Professor Charles Swanton, Cancer Research UK’s chief clinician said remarkable adaptability and resilience has been shown by NHS staff, with hospitals providing COVID-19 free spaces and tele consultations.

“But we also know cancer patients faced a lot more uncertainty than usual and last-minute changes to their care, as a result of the pandemic.

“Although there are challenges in the health system, it’s very important that anyone who has noticed an unusual change in their body, gets in touch with their GP.

And if it’s tricky getting an appointment, do keep trying because your GP wants to hear from you. Early diagnosis can make all the difference.”

The crisis is far from over

Monthly numbers of patients starting treatment are now similar to, or slightly higher than pre-pandemic levels, but this was not the case for most of the pandemic, with thousands fewer patients starting treatment during the pandemic than expected.

And more work will need to be done to ensure that the tens of thousands of people still waiting for tests and treatments are able to access them as soon as possible.

Cancer Research UK continues to support the government’s ambition of diagnosing 3 in 4 patients with cancer at an early stage by 2028.

However, this will only be possible with significant investment in cancer services.

Mitchell added: “I’m asking Sajid Javid to make it his mission to improve cancer survival in this country, by securing long term investment to sufficiently fund the cancer workforce and ensure the NHS has the equipment it needs to diagnose more patients early.”

More on this topic

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer that’s not spread elsewhere in the body. “Today’s results are the...

New Combination of Old Drugs Improves Survival in Patients with Prostate Cancer [ESMO Congress 2021 Press Release]

LBA4_PR - Abiraterone acetate plus prednisolone (AAP) with or without enzalutamide (ENZ) added to androgen deprivation therapy (ADT) compared to ADT alone for men...

Immunotherapy Prolongs Survival in Recurrent, Persistent or Metastatic Cervical Cancer [ESMO Congress 2021 Press Release]

LBA2_PR - Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer: Randomized, double-blind, phase 3 KEYNOTE-826 study N. Colombo1, C....

Woman Diagnosed with Breast Cancer at 33 Launches Self-Examination App

Jessica Baladad has had a long history with self-examinations after a breast cancer scare in her early 20s. This habit helped save her life,...

Extended Adjuvant Treatment with Letrozole Results in Longer Survival in Postmenopausal Patients with Breast Cancer

According to results from a prospective, open-label, phase III study conducted in 69 Italian hospitals within the Gruppo Italiano Mammella among the postmenopausal patients...

Foodie Fridays: Apple Bok Choy Salad

While the temps may still be in the 80’s, apple season is upon us! Give this Apple Bok Choy salad a try!  It is...